DJIA 17,050.75 138.46 0.82%
NASDAQ 4,810.79 19.64 0.41%
S&P 500 2,013.43 17.60 0.88%
market minute promo

Merck & Co., Inc. (NYSE: MRK)

51.02 0.07 (0.14%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

MRK $51.02 0.14%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $50.66
Previous Close $50.95
Daily Range $50.14 - $51.19
52-Week Range $45.69 - $63.62
Market Cap $143.7B
P/E Ratio 15.03
Dividend (Yield) $1.80 (3.5%)
Ex-Dividend Date
Dividend Pay Date
Volume 12,522,377
Average Daily Volume 15,024,344
Current FY EPS $3.50




Drug Makers

Merck & Co., Inc. (MRK) Description

A global research-driven pharmaceutical company that discovers, develops, manufactures and markets a range of innovative products to improve human and animal health. Website:

News & Commentary

Gilead Is About to Disappoint Investors -- but for All the Right Reasons

Wall Street is hoping Gilead is gearing up for a major buyout soon. One Motley Fool thinks this scenario is both unlikely and unnecessary. Here's why.

Merck KGaA/Pfizer's Avelumab Gets Fast Track Status

Stocks Are Slightly Lower as Biotech Leads Losses

iShares Global Healthcare ETF Experiences Big Outflow

Dow Movers: AAPL, DD

Gilead's Next Logical Acquisition, Part 1: NASH And Galmed

See Which Of The Latest 13F Filers Holds Merck & Co.

The 4 Stocks That Boosted the Dow on Wednesday

3 Health Care Stocks Nudging The Sector Higher

CytomX IPO Could Pop, But Long-Term Returns Are Uncertain

See More MRK News...

MRK's Top Competitors

MRK $51.02 (0.14%)
Current stock: MRK
JNJ $95.08 (0.11%)
Current stock: JNJ
NVS $92.61 (1.10%)
Current stock: NVS
RHHBY $33.29 (2.26%)
Current stock: RHHBY